Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia
- Status
- TERMINATED
- Phase
- PHASE3
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Food Effects on the Relative Bioavailability of Different Dosages of Risedronate
- Status
- COMPLETED
- Phase
- PHASE1
CASTLE (Clopidogrel And Serum Troponin Level Elevation)
- Status
- COMPLETED
- Phase
- PHASE3
Prospective Registry of Outcomes and Management of Acute Ischaemic Syndromes
- Status
- COMPLETED
- Phase
- NA
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
- Status
- COMPLETED
- Phase
- PHASE3
Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility
- Status
- TERMINATED
- Phase
- PHASE3
Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea
- Status
- COMPLETED
- Phase
- PHASE3
Acceptability of Lactacyd Femina
- Status
- COMPLETED
- Phase
- PHASE4
GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN)
- Status
- COMPLETED
- Phase
- NA
Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)
- Status
- COMPLETED
- Phase
- PHASE4
ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination
- Status
- COMPLETED
- Phase
- PHASE4
GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- Status
- COMPLETED
- Phase
- PHASE3